## Primary Carnitine Deficiency: Etiology and Pathophysiology **Key Point:** Primary carnitine deficiency is most commonly caused by mutations in the *SLC22A5* gene, which encodes the organic cation transporter 2 (OCTN2), responsible for renal reabsorption and intestinal absorption of carnitine. ### Genetic Basis and Frequency | Defect | Gene | Protein | Inheritance | Frequency | Pathophysiology | |--------|------|---------|-------------|-----------|------------------| | **Primary carnitine deficiency** | *SLC22A5* | OCTN2 transporter | Autosomal recessive | Most common | ↓ Carnitine reabsorption → systemic deficiency | | CPT I deficiency | *CPT1A* | CPT I (hepatic) | Autosomal recessive | Rare | ↓ Carnitine shuttle entry; hypoketotic hypoglycemia | | CPT II deficiency | *CPT2* | CPT II (inner membrane) | Autosomal recessive | Rare | ↓ Acyl-carnitine exit; muscle pain, rhabdomyolysis | | ACAD deficiency | *ACAD9*, *ACAD10* | Acyl-CoA dehydrogenase | Autosomal recessive | Rare | ↓ β-oxidation initiation | ### Why OCTN2 (Organic Cation Transporter 2)? 1. **Renal reabsorption:** OCTN2 is the primary transporter for carnitine reabsorption in the proximal tubule; mutations cause massive urinary losses. 2. **Intestinal absorption:** OCTN2 also mediates carnitine uptake in the small intestine; defects reduce dietary carnitine bioavailability. 3. **Systemic consequence:** Loss of both reabsorption and absorption pathways leads to severe, generalized carnitine depletion affecting all tissues (heart, skeletal muscle, liver). 4. **Clinical presentation:** Hypoketotic hypoglycemia (impaired mitochondrial β-oxidation), cardiomyopathy, hepatic encephalopathy, and muscle weakness. **High-Yield:** Primary carnitine deficiency is an autosomal recessive disorder caused by *SLC22A5* mutations and is the most common inherited carnitine disorder; it is treatable with oral L-carnitine supplementation. **Mnemonic:** **OCTN2 = Organic Cation TraNsporter 2** — the gatekeeper of carnitine homeostasis; loss of this transporter = loss of carnitine. **Clinical Pearl:** The hypoketotic hypoglycemia in primary carnitine deficiency is pathognomonic: despite severe hypoglycemia, ketone bodies are NOT elevated because the block in carnitine-dependent fatty acid oxidation prevents ketogenesis. This distinguishes it from other causes of hypoglycemia. ### Differential Diagnosis: Why Not the Others? ```mermaid flowchart TD A[Carnitine Deficiency Suspected]:::outcome --> B{Clinical Presentation?}:::decision B -->|Hypoketotic hypoglycemia + hepatomegaly + low carnitine| C[Primary Carnitine Deficiency]:::action C --> D[OCTN2 mutation - SLC22A5]:::outcome B -->|Muscle pain + rhabdomyolysis + normal carnitine| E[CPT II Deficiency]:::action B -->|Hypoketotic hypoglycemia + normal carnitine| F[CPT I Deficiency]:::action B -->|Elevated acyl-carnitines| G[ACAD Deficiency]:::action ```
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.